HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

3- amino- N- (4- methoxybenzyl)- 4,6- dimethylthieno(2,3- b)pyridine- 2- carboxamide

structure in first source
Also Known As:
VU0152100
Networked: 3 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Brugnoli, Alberto: 1 article (10/2020)
2. Morari, Michele: 1 article (10/2020)
3. Pisanò, Clarissa Anna: 1 article (10/2020)
4. Cieślik, Paulina: 1 article (01/2019)
5. Kalinowski, Leszek: 1 article (01/2019)
6. Kusek, Magdalena: 1 article (01/2019)
7. Pelikant-Małecka, Iwona: 1 article (01/2019)
8. Pilc, Andrzej: 1 article (01/2019)
9. Płoska, Agata: 1 article (01/2019)
10. Radulska, Adrianna: 1 article (01/2019)

Related Diseases

1. Schizophrenia (Dementia Praecox)
2. Cognitive Dysfunction
3. Dyskinesias (Dyskinesia)

Related Drugs and Biologics

1. 1- (4- methoxybenzyl)- 5- (trifluoromethoxy)indoline- 2,3- dione
2. VU0357017
3. Cholinergic Agents (Cholinergics)
4. N,N'- dicyclopentyl- 2- methylsulfanyl- 5- nitro- pyrimidine- 4,6- diamine
5. Dizocilpine Maleate (Dizocilpine)
6. Muscarinic Receptors (Muscarinic Acetylcholine Receptor)
7. Levodopa (L Dopa)
8. N- (4- (2- methoxyphenoxy)phenyl)- N- (2,2,2- trifluoroethylsulfonyl)pyrid- 3- ylmethylamine